ACP
BBOT
Acuta Capital Partners’s BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.99M | Hold |
187,257
| – | – | 2.78% | 14 |
|
|
2025
Q1 | $2.12M | Buy |
187,257
+6,312
| +3% | +$71.3K | 2.45% | 16 |
|
|
2024
Q4 | $1.9M | Hold |
180,945
| – | – | 1.91% | 17 |
|
|
2024
Q3 | $1.89M | Buy |
180,945
+3,109
| +2% | +$32.5K | 1.53% | 20 |
|
|
2024
Q2 | $1.82M | Buy |
+177,836
| New | +$1.82M | 1.53% | 22 |
|